Transcatheter Arterial Chemoembolization
Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma
... Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma RESEARCH Open Access Clinical efficacy of postoperative adjuvant transcatheter arterial[.] ...
9
Original Article Efficacy of sorafenib as second-line of treatment in transcatheter arterial chemoembolization (TACE)-resistant hepatocellular carcinoma (HCC)
... According to the Barcelona Clinic Liver Cancer (BCLC) staging system, transcatheter arterial chemoembolization (TACE) has been estab- lished as the standard treatment for intermedi- ate stage HCC ...
10
Meta-analysis: preoperative transcatheter arterial chemoembolization does not improve prognosis of patients with resectable hepatocellular carcinoma
... Transcatheter arterial chemoembolization (TACE), which induces tumor ischemic necrosis by arterial injection of chemotherapeutic drugs and embolizing agents, is recommended as the first-line ...
11
Visceral Fat Accumulation Is Associated with Increased Mortality Rate after Transcatheter Arterial Chemoembolization in Patients with Hepatocellular Carcinoma
... Aim: Transcatheter arterial chemoembolization (TACE) is thought to be a safe and effective treat- ment for hepatocellular carcinoma (HCC). However, in some HCC patients, it potentially shortens ...
13
Review Article Transcatheter arterial chemoembolization in combination with stereotactic body radiation therapy in primary liver carcinoma: a systematic review and meta-analysis
... that transcatheter arterial chemoembolization (TACE) combined with ste- reotactic body radiation therapy (SBRT), also referred to as Gamma Knife therapy, might have a synergistic effect on the ...
12
Treatment with transcatheter arterial chemoembolization induces an increase of the L-selectin<sup>low</sup> CXCR3+ CD8+ T cell subset in patients with hepatocellular carcinoma
... segmental arterial chemoembolization using anticancer drugs was performed comprising 1000 mg of 5-fluorouracil, 20 mg of hydroxycamptothecin cisplatin or 10–20 mg of mitomycin C, and then 5–20 mL ethiodized ...
7
Transcatheter arterial chemoembolization improves the resectability of malignant breast phyllodes tumor with angiosarcoma component: a case report
... that transcatheter arterial chemoembolization (TACE) can improve the resectability of malignant phyllodes tumor of the breast without requiring skin ...
7
Evaluation of efficacy of transcatheter arterial chemoembolization for hepatocellular carcinoma using magnetic resonance diffusion-weighted imaging
... of transcatheter arterial chemoembolization (TACE) has been recommended as first-line therapy for nonsurgical patients with hepatocellular carci- noma (HCC), it is difficult to accurately predict the ...
7
Contrast Induced Nephropathy in Patients with Hepatocellular Carcinoma Undergoing Transcatheter Arterial Chemoembolization
... Purpose: The purpose of this retrospective study was to assess the incidence and the risk factors of contrast-induced nephropathy (CIN) following transcatheter arterial chemoembolization (TACE) in ...
7
Original Article Transcatheter arterial chemoembolization for patients with hepatic metastasis of nonfunctional pancreatic neuroendocrine neoplasms
... of transcatheter arterial chemoembolization (TACE) for unresectable hepatic metastatic nonfunctional ...of transcatheter arterial chemoembolization were operated and the mean ...
11
Effects of Transcatheter Arterial Chemoembolization for Unresectable Hepatocellular Carcinoma Using a Combination of Platinum Agents (Cisplatin plus Miriplatin): A Retrospective Comparison with Cisplatin Monotherapy
... Background: Miriplatin is a slow-release, lipophilic platinum complex, de- veloped to produce a superior antitumor effect for hepatocellular carcinoma (HCC). However, the miriplatin suspension is highly viscous and can ...
14
<p>Prognostic significance of lymphocyte-to-monocyte ratio and platelet-to-lymphocyte ratio in patients with hepatocellular carcinoma undergoing transcatheter arterial chemoembolization and radiofrequency ablation</p>
... undergoing transcatheter arterial chemoembolization (TACE) and RFA, 204 cases with HCC which accepted RFA and TACE were retrospectively analyzed and assigned into 2 groups based on optimal cutoff ...
9
Transcatheter arterial chemoembolization monotherapy vs combined transcatheter arterial chemoembolization–percutaneous microwave coagulation therapy for massive hepatocellular carcinoma (≥10 cm)
... of transcatheter arterial chemoembolization (TACE) or TACE combined with percutaneous microwave coagulation therapy (PMCT) and the long-term survival rate of MHCC patients treated with these ...
10
Original Article Bear bile powder suppresses the increase of IL-8 and improves liver function post transcatheter arterial chemoembolization in hepatocellular carcinoma patients
... Abstract: Transcatheter arterial chemoembolization (TACE), the main therapeutic method for unresectable hepa- tocellular carcinoma (HCC), may induce the release of a large number of proinflammatory ...
7
Five-year outcome of conventional and drug-eluting transcatheter arterial chemoembolization in patients with hepatocellular carcinoma
... tumor resection [6]. Conventional TACE (cTACE) involves the delivery of embolic material to the tumor plus chemo- therapeutic agents such as doxorubicin, either dissolved or emulsified in lipiodol, which is noted for ...
9
Transcatheter arterial chemoembolization combined with CT-guided percutaneous thermal ablation versus hepatectomy in the treatment of hepatocellular carcinoma
... TACE was performed prior to ablation and by following previously described techniques [11]. The volume of lipio- dol and the dose of chemotherapeutics depended on the volume and blood supply of the targeted tumor, as ...
10
Hepatocellular carcinoma associated with budd-chiari syndrome: imaging features and transcatheter arterial chemoembolization
... Figure 3 51-year-old woman with HCC in BCS. (a) Contrast-enhanced transverse CT scan showing a large mild heterogeneous enhanced nodule( ⇦ ) in the left liver during arterial phase and obvious cirsoid azygous vein ...
8
<p>Efficacy Of Apatinib In Transcatheter Arterial Chemoembolization (TACE) Refractory Intermediate And Advanced-Stage Hepatocellular carcinoma：A Propensity Score Matching Analysis</p>
... Results: Before PSM analysis, the median OS and PFS were 17.0 and 7.0 months in the TACE- apatinib group, while 8.5 and 2.5 months in the TACE-alone group (P<0.05). After PSM analysis, 29 pairs of patients were ...
10
Inhibition of microRNA-126 promotes the expression of Spred1 to inhibit angiogenesis in hepatocellular carcinoma after transcatheter arterial chemoembolization: in vivo study
... Abstract: MicroRNA-126 (miR-126) has been found to promote angiogenesis, but the underlying mechanisms are still unclear. So, we conducted this study to explore the effect of miR-126 expression on angiogenesis in ...
11
Percutaneous microwave ablation combined with synchronous transcatheter arterial chemoembolization for the treatment of colorectal liver metastases: results from a follow-up cohort
... and arterial blood supply of the ...patency. Chemoembolization was administered via the tar- geted artery using a mixture of chemotherapeutic agents, which consisted of 50–150 mg oxaliplatin, 10–50 mg ...
7